We are hiring an Omics Scientist/Customer Consultant
August 7, 2025 | Louis Loeb
We are seeking a new colleague to join us in supporting
scientists from various industries, including pharmaceutical,
biotech, food technology, and academia, in their omics research
projects. We are looking for a highly skilled and motivated
individual with a passion for Omics and customer consulting. The
role requires you have experience within at least one of
following areas: transcriptomics, metabolomes or proteomics.
This includes knowledge of sample requirements, different
approaches to sample analysis, and hands-on experience with data
interpretation and analysis. You also need to be experienced R
user, as the work include execution, optimization and
development of analytical pipelines in R or python.
Read article
Join our team as a Bioinformatician
December 2, 2024 | Louis Loeb
We are seeking a new colleague to join us in supporting
scientists from various industries, including pharmaceutical,
biotech, food technology, and academia, in their omics research
projects. Biogenity is seeking a full-time bioinformatician to
join our team in Aalborg, Denmark, working on a five-year EU
project as well as customer-related projects. We are seeking a
talented and driven Bioinformatician to join our dynamic team
starting February 1, 2025. In this role, you will contribute to
the development of innovative bioinformatics tools, analyze
complex biological data, and collaborate with leading
researchers in the field. You will be involved in a large
five-year EU-project, the EXPOSIM project, and will be
responsible for leading and completing tasks related to text
mining, omics integration, machine learning, network analysis,
and meta-analysis. You will also be a part of our data science
team, analyzing client data and developing, optimizing and
maintaining data analytical pipelines.
Read article
Biogenity Partners with Centre for Diagnostics at DTU to Expand
with Olink Proteomics Workflows
February 28, 2024 | Louis Loeb
Are you searching for diagnostic or prognostic markers when
performing large cohort studies, assessing the effect of
treatments, or conducting basic research? We at Biogenity are
excited to announce our new partnership with the Centre for
Diagnostics at DTU. This alliance marks a significant milestone
for the life science community, offering a streamlined,
end-to-end workflow from sample to biological insight, utilizing
the comprehensive capabilities of Olink proteomics and
Biogenity’s data analysis pipeline.
Read article
Attending the Danish Society for Extracellular Vesicles Annual
Meeting as a Sponsor
October 4, 2023 | Louis Loeb
It's an exciting moment for us at Biogenity as we gear up to
attend the Annual Meeting of The Danish Society for
Extracellular Vesicles (DSEV) as proud sponsors on October 5,
2023. The event promises to be a gathering of bright minds,
bringing together researchers and companies dedicated to
studying extracellular vesicles, exosomes, and microvesicles.
DSEV is commendably bridging the gap between Danish scientists
and the global EV research community, and being a part of this
dynamic ecosystem is a privilege for us.
Read article
Biogenity Joins Forces with TAmiRNA
January 16, 2023 | Louis Loeb
Biogenity and TAmiRNA, an Austrian biotech company specializing
in transcriptomics, has entered into a partnership to enable
Multiomics workflows combining Proteomics and Transcriptomics.
Kenneth Kastaniegaard, CEO of Biogenity, commented:"TAmiRNA is a
well-established player in the field of transcriptomics, with a
focus on using microRNA (miRNA) as diagnostic and therapeutic
targets. Combining this data with proteomics can bring essential
insight into molecular signals and the biological response they
cause.
Read article